오메가 3 보충제 시장 : 유래별, 형태별, 기능별, 유통 채널별, 최종사용자별, 지역별(2025-2033년)

The global omega 3 supplements market size reached USD 8.4 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 15.6 Billion by 2033, exhibiting a growth rate (CAGR) of 6.7% during 2025-2033. The market is driven by increasing health awareness, rising prevalence of cardiovascular diseases, growing demand for dietary supplements, several health benefits associated with omega-3 supplements and the rising aging population.

Omega-3 fatty acids are essential fats found naturally in foods like fish, vegetable oils, nuts, flax seeds, flaxseed oil, and leafy vegetables. They play a pivotal role in the cell membranes of the body for affecting the functions of cell receptors. Their deficiency can lead to dry and irritated skin, inflammation, dry eyes, depression, and arthritis. As a result, there is a rise in the need for over the counter (OTC) omega-3 supplements to help boost the omega-3 levels in the body. These supplements generally contain different forms of omega-3s, including natural triglycerides, free fatty acids, ethyl esters, re-esterified triglycerides, and phospholipids.

Omega 3 Supplements Market Trends:

A significant rise in the number of individuals suffering from omega-3 deficiency represents one of the key factors bolstering the market growth. Moreover, omega-3 fatty acids play an essential role in improving cardiovascular health and enhancing communication between brain cells. Therefore, the increasing prevalence of heart diseases and the growing consumer inclination towards cognitive health are contributing to the market growth. Apart from this, the rising awareness about the benefits of including omega-3 fatty acids in the diet for reducing the risk of blood clots, keeping the lining of the arteries smooth and free from damage, and lowering triglyceride levels is also driving the market. Furthermore, some of these supplements made from fish oil are considered nonvitamin and nonmineral natural products, which makes them a popular choice among children and adults. Besides this, manufacturers are offering sustainably sourced plant-based variants to cater to the dietary requirements of omega-3 among the vegan population. This, along with the emerging trend of veganism, is anticipated to propel market growth.

Key Market Segmentation:

Breakup by Source:

• Fish Oil
• Krill Oil
• Algae Oil
• Others

Breakup by Form:

• Tablets
• Capsules
• Soft Gels
• Others

Breakup by Functionality:

• Cardiovascular Health
• Brain, Nervous System and Mental Health
• Eye Diseases
• Diabetes
• Others

Breakup by Distribution Channel:

• OTC
• Prescribed

Breakup by End User:

• Adults
• Geriatric
• Pregnant Women
• Children
• Infants

Breakup by Region:

• North America
• United States
• Canada
• Asia-Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Others
• Latin America
• Brazil
• Mexico
• Others
• Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being 1-800-Flowers.com Inc., Aker BioMarine ASA, Carlson Labs, Green Pasture Products LLC, KD Pharma Group, Natrol LLC, Nordic Naturals Inc., Now Foods, NutriGold Inc., OmegaBrite, Optimum Nutrition Inc. (Glanbia Performance Nutrition Inc.), Pharma Nord and The Bountiful Company.

Key Questions Answered in This Report

• 1.What was the size of the global omega 3 supplements market in 2024?
• 2.What is the expected growth rate of the global omega 3 supplements market during 2025-2033?
• 3.What has been the impact of COVID-19 on the global omega 3 supplements market?
• 4.What are the key factors driving the global omega 3 supplements market?
• 5.What is the breakup of the global omega 3 supplements market based on the source?
• 6.What is the breakup of the global omega 3 supplements market based on the form?
• 7.What is the breakup of the global omega 3 supplements market based on the functionality?
• 8.What is the breakup of the global omega 3 supplements market based on the distribution channel?
• 9.What is the breakup of the global omega 3 supplements market based on the end user?
• 10.What are the key regions in the global omega 3 supplements market?
• 11.Who are the key players/companies in the global omega 3 supplements market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Omega 3 Supplements Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Source

• 6.1 Fish Oil
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Krill Oil
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Algae Oil
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast
• 6.4 Others
  • 6.4.1 Market Trends
  • 6.4.2 Market Forecast

7 Market Breakup by Form

• 7.1 Tablets
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Capsules
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Soft Gels
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast
• 7.4 Others
  • 7.4.1 Market Trends
  • 7.4.2 Market Forecast

8 Market Breakup by Functionality

• 8.1 Cardiovascular Health
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Brain, Nervous System and Mental Health
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Eye Diseases
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 Diabetes
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast
• 8.5 Others
  • 8.5.1 Market Trends
  • 8.5.2 Market Forecast

9 Market Breakup by Distribution Channel

• 9.1 OTC
  • 9.1.1 Market Trends
  • 9.1.2 Market Forecast
• 9.2 Prescribed
  • 9.2.1 Market Trends
  • 9.2.2 Market Forecast

10 Market Breakup by End User

• 10.1 Adults
  • 10.1.1 Market Trends
  • 10.1.2 Market Forecast
• 10.2 Geriatric
  • 10.2.1 Market Trends
  • 10.2.2 Market Forecast
• 10.3 Pregnant Women
  • 10.3.1 Market Trends
  • 10.3.2 Market Forecast
• 10.4 Children
  • 10.4.1 Market Trends
  • 10.4.2 Market Forecast
• 10.5 Infants
  • 10.5.1 Market Trends
  • 10.5.2 Market Forecast

11 Market Breakup by Region

• 11.1 North America
  • 11.1.1 United States
    • 11.1.1.1 Market Trends
    • 11.1.1.2 Market Forecast
  • 11.1.2 Canada
    • 11.1.2.1 Market Trends
    • 11.1.2.2 Market Forecast
• 11.2 Asia-Pacific
  • 11.2.1 China
    • 11.2.1.1 Market Trends
    • 11.2.1.2 Market Forecast
  • 11.2.2 Japan
    • 11.2.2.1 Market Trends
    • 11.2.2.2 Market Forecast
  • 11.2.3 India
    • 11.2.3.1 Market Trends
    • 11.2.3.2 Market Forecast
  • 11.2.4 South Korea
    • 11.2.4.1 Market Trends
    • 11.2.4.2 Market Forecast
  • 11.2.5 Australia
    • 11.2.5.1 Market Trends
    • 11.2.5.2 Market Forecast
  • 11.2.6 Indonesia
    • 11.2.6.1 Market Trends
    • 11.2.6.2 Market Forecast
  • 11.2.7 Others
    • 11.2.7.1 Market Trends
    • 11.2.7.2 Market Forecast
• 11.3 Europe
  • 11.3.1 Germany
    • 11.3.1.1 Market Trends
    • 11.3.1.2 Market Forecast
  • 11.3.2 France
    • 11.3.2.1 Market Trends
    • 11.3.2.2 Market Forecast
  • 11.3.3 United Kingdom
    • 11.3.3.1 Market Trends
    • 11.3.3.2 Market Forecast
  • 11.3.4 Italy
    • 11.3.4.1 Market Trends
    • 11.3.4.2 Market Forecast
  • 11.3.5 Spain
    • 11.3.5.1 Market Trends
    • 11.3.5.2 Market Forecast
  • 11.3.6 Russia
    • 11.3.6.1 Market Trends
    • 11.3.6.2 Market Forecast
  • 11.3.7 Others
    • 11.3.7.1 Market Trends
    • 11.3.7.2 Market Forecast
• 11.4 Latin America
  • 11.4.1 Brazil
    • 11.4.1.1 Market Trends
    • 11.4.1.2 Market Forecast
  • 11.4.2 Mexico
    • 11.4.2.1 Market Trends
    • 11.4.2.2 Market Forecast
  • 11.4.3 Others
    • 11.4.3.1 Market Trends
    • 11.4.3.2 Market Forecast
• 11.5 Middle East and Africa
  • 11.5.1 Market Trends
  • 11.5.2 Market Breakup by Country
  • 11.5.3 Market Forecast

12 SWOT Analysis

• 12.1 Overview
• 12.2 Strengths
• 12.3 Weaknesses
• 12.4 Opportunities
• 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

• 14.1 Overview
• 14.2 Bargaining Power of Buyers
• 14.3 Bargaining Power of Suppliers
• 14.4 Degree of Competition
• 14.5 Threat of New Entrants
• 14.6 Threat of Substitutes

15 Price Analysis

16 Competitive Landscape

• 16.1 Market Structure
• 16.2 Key Players
• 16.3 Profiles of Key Players
  • 16.3.1 1-800-Flowers.com Inc.
    • 16.3.1.1 Company Overview
    • 16.3.1.2 Product Portfolio
  • 16.3.2 Aker BioMarine ASA
    • 16.3.2.1 Company Overview
    • 16.3.2.2 Product Portfolio
  • 16.3.3 Carlson Labs
    • 16.3.3.1 Company Overview
    • 16.3.3.2 Product Portfolio
  • 16.3.4 Green Pasture Products LLC
    • 16.3.4.1 Company Overview
    • 16.3.4.2 Product Portfolio
  • 16.3.5 KD Pharma Group
    • 16.3.5.1 Company Overview
    • 16.3.5.2 Product Portfolio
  • 16.3.6 Natrol LLC
    • 16.3.6.1 Company Overview
    • 16.3.6.2 Product Portfolio
  • 16.3.7 Nordic Naturals Inc.
    • 16.3.7.1 Company Overview
    • 16.3.7.2 Product Portfolio
  • 16.3.8 Now Foods
    • 16.3.8.1 Company Overview
    • 16.3.8.2 Product Portfolio
  • 16.3.9 NutriGold Inc.
    • 16.3.9.1 Company Overview
    • 16.3.9.2 Product Portfolio
  • 16.3.10 OmegaBrite
    • 16.3.10.1 Company Overview
    • 16.3.10.2 Product Portfolio
  • 16.3.11 Optimum Nutrition Inc. (Glanbia Performance Nutrition Inc.)
    • 16.3.11.1 Company Overview
    • 16.3.11.2 Product Portfolio
  • 16.3.12 Pharma Nord
    • 16.3.12.1 Company Overview
    • 16.3.12.2 Product Portfolio
  • 16.3.13 The Bountiful Company
    • 16.3.13.1 Company Overview
    • 16.3.13.2 Product Portfolio